<DOC>
	<DOCNO>NCT02988505</DOCNO>
	<brief_summary>Lymphedema frequent chronic condition pose high burden patient . Clinical guideline emphasize role compression therapy prescription medical device . Even mandatory publicly fund health insurance system , out-of-pocket payment ( OOPP ) may exist due price reimbursement set process . OOPP may threaten equity care drive patient forgo care . Our aim analyze distributive effect OOPP lymphedema patient France . A prospective , multicenter study conduct France 2014 patient lymphedema . Household ability pay specify net income OOPP assess prospectively 6 month outpatient care ( visit , drug , medical device , nurse care , biological test , image , physiotherapy transportation ) . Both mandatory voluntary health insurance reimbursement consider . We combine concentration curve concentration index assess distributive effect .</brief_summary>
	<brief_title>Out-of Pocket Payments With Lymphedema France</brief_title>
	<detailed_description />
	<mesh_term>Lymphedema</mesh_term>
	<criteria>Inclusion criterion : Patient age six year , primary secondary lymphedema , regardless severity disease ; Patient treat one centre participate study ; Patient ( legal representative minor ) give write consent [ refuse participate , accord local Law ] ; Patient Internet access active email address . Exclusion criterion : Patients concomitant chronic venous insufficiency ; Patient cover health care insurance scheme ; People protect law .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>